Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-006)
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this phase III, open-label study is to determine the safety and tolerability of cyclosporine in the treatment of dry eye syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 24, 2007
CompletedFirst Posted
Study publicly available on registry
October 25, 2007
CompletedOctober 25, 2007
October 1, 2007
October 24, 2007
October 24, 2007
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Diagnosis of dry eye syndrome
You may not qualify if:
- Intraocular or refractive surgery in the study eye within 3 months prior to study start
- Unwilling to discontinue use of contact lenses during the study
- Pregnancy or lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clayton Eye Center
Morrow, Georgia, 30260, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Roger Vogel
Sirion Therapeutics
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
October 24, 2007
First Posted
October 25, 2007
Last Updated
October 25, 2007
Record last verified: 2007-10